Company Info

Company Info

RATIO ANALYSIS

Genomic Valley Biotech Ltd.

You can view the ratio analysis for the last 5 years.
GO

BSE

Jan 09
25.69 -0.29 ( -1.12%)
Volume 170
Prev. Close 25.98
Open Price 25.98
Today's Low / High
23.10
     
25.98
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
21.01
     
94.00
Genomic Valley Biotech Ltd.is not traded in NSE
ISIN No INE574D01010 Market Cap. ( in Cr. ) 7.85 P/BV 2.00 Book Value ( ) 12.85
BSE Code 539206 52 Week High/Low ( ) 94/21 FV/ML 10/1 P/E(X) 22.05
NSE Code - Book Closure 30/12/2024 EPS ( ) 1.17 Div Yield (%) 0.00
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)1.170.052.12-0.03-1.83
Diluted EPS (Rs.)1.170.052.12-0.03-1.83
Cash EPS (Rs.)1.170.052.150.24-1.21
Book Value[Excl.RevalReserv]/Share (Rs.)12.7611.6011.559.4214.69
Book Value[Incl.RevalReserv]/Share (Rs.)12.7611.6011.559.4214.69
Revenue From Operations / Share (Rs.)2.760.548.910.230.68
PBDIT / Share (Rs.)1.450.053.02-0.96-0.44
PBIT / Share (Rs.)1.450.042.99-1.24-1.06
PBT / Share (Rs.)1.450.042.12-1.38-1.64
Net Profit / Share (Rs.)1.170.042.12-0.03-1.83
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)52.609.8333.83-416.43-64.94
PBIT Margin (%)52.309.1733.54-535.97-155.88
PBT Margin (%)52.309.1723.83-596.37-241.16
Net Profit Margin (%)42.199.1923.81-13.23-268.67
Return on Networth / Equity (%)9.130.4218.38-0.32-12.45
Return on Capital Employeed (%)11.320.4225.89-10.55-4.80
Return On Assets (%)8.170.3514.66-0.24-7.33
Long Term Debt / Equity (X)0.000.000.000.000.34
Total Debt / Equity (X)0.000.160.170.000.34
Asset Turnover Ratio (%)0.190.030.660.010.02
      
LIQUIDITY RATIOS     
      
Current Ratio (X)5.733.682.885.310.18
Quick Ratio (X)5.103.682.885.310.18
Inventory Turnover Ratio (X)0.000.000.000.000.08
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)0.000.000.00-6.89-0.76
Interest Coverage Ratio (Post Tax) (%)0.000.000.00-9.05-2.15
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)17.8511.207.217.568.74
EV / Net Operating Revenue (X)21.1567.842.65107.1042.02
EV / EBITDA (X)40.21689.517.83-25.72-64.70
MarketCap / Net Operating Revenue (X)21.2164.232.44107.1434.64
Price / BV (X)4.592.991.882.631.61
Price / Net Operating Revenue (X)21.2164.282.44107.1434.65
EarningsYield0.010.000.090.00-0.07